| Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression R Waziry, B Hajarizadeh, J Grebely, J Amin, M Law, M Danta, J George, ... Journal of hepatology 67 (6), 1204-1212, 2017 | 504 | 2017 |
| The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection J Grebely, K Page, R Sacks‐Davis, MS van der Loeff, TM Rice, J Bruneau, ... Hepatology 59 (1), 109-120, 2014 | 501 | 2014 |
| Life expectancy of HIV‐positive people after starting combination antiretroviral therapy: a meta‐analysis S Teeraananchai, SJ Kerr, J Amin, K Ruxrungtham, MG Law HIV medicine 18 (4), 256-266, 2017 | 472 | 2017 |
| Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population AJ Rodger, R Lodwick, M Schechter, S Deeks, J Amin, R Gilson, ... Aids 27 (6), 973-979, 2013 | 418 | 2013 |
| Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial A Carr, C Workman, DE Smith, J Hoy, J Hudson, N Doong, A Martin, ... Jama 288 (2), 207-215, 2002 | 392 | 2002 |
| Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study A Martin, DE Smith, A Carr, C Ringland, J Amin, S Emery, J Hoy, ... Aids 18 (7), 1029-1036, 2004 | 371 | 2004 |
| Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study J Amin, MG Law, M Bartlett, JM Kaldor, GJ Dore The Lancet 368 (9539), 938-945, 2006 | 343 | 2006 |
| Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study AE Grulich, R Guy, J Amin, F Jin, C Selvey, J Holden, HMA Schmidt, ... The lancet HIV 5 (11), e629-e637, 2018 | 325 | 2018 |
| Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial J Grebely, O Dalgard, B Conway, EB Cunningham, P Bruggmann, ... The lancet Gastroenterology & hepatology 3 (3), 153-161, 2018 | 300 | 2018 |
| Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial A Martin, M Bloch, J Amin, D Baker, DA Cooper, S Emery, A Carr, ... Clinical Infectious Diseases 49 (10), 1591-1601, 2009 | 299 | 2009 |
| The pattern of excess cancer in dialysis and transplantation JH Stewart, CM Vajdic, MT Van Leeuwen, J Amin, AC Webster, ... Nephrology Dialysis Transplantation 24 (10), 3225-3231, 2009 | 241 | 2009 |
| Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study MT Van Leeuwen, AC Webster, MRE McCredie, JH Stewart, ... Bmj 340, 2010 | 191 | 2010 |
| Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study J Amin, GJ Dore, DL O’Connell, M Bartlett, E Tracey, JM Kaldor, MG Law Journal of hepatology 45 (2), 197-203, 2006 | 187 | 2006 |
| Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority … ENCORE1 Study Group The Lancet 383 (9927), 1474-1482, 2014 | 182 | 2014 |
| HIV and hepatitis C coinfection within the CAESAR study J Amin, M Kaye, S Skidmore, D Pillay, DA Cooper, GJ Dore HIV medicine 5 (3), 174-179, 2004 | 182 | 2004 |
| Quantifying the dose-response of walking in reducing coronary heart disease risk: meta-analysis H Zheng, N Orsini, J Amin, A Wolk, VTT Nguyen, F Ehrlich European journal of epidemiology 24, 181-192, 2009 | 165 | 2009 |
| Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation MT Van Leeuwen, AE Grulich, AC Webster, MRE McCredie, JH Stewart, ... Blood, The Journal of the American Society of Hematology 114 (3), 630-637, 2009 | 164 | 2009 |
| A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand GV Matthews, A Avihingsanon, SR Lewin, J Amin, R Rerknimitr, ... Hepatology 48 (4), 1062-1069, 2008 | 162 | 2008 |
| Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study J Grebely, FMJ Lamoury, B Hajarizadeh, Y Mowat, AD Marshall, S Bajis, ... The lancet Gastroenterology & hepatology 2 (7), 514-520, 2017 | 161 | 2017 |
| Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis DA Brown, C Stephan, RL Ward, M Law, M Hunter, AR Bauskin, J Amin, ... Clinical Cancer Research 12 (1), 89-96, 2006 | 158 | 2006 |
